Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
about
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Metabolic and hepatic effects ...... nonalcoholic steatohepatitis.
@en
Metabolic and hepatic effects ...... nonalcoholic steatohepatitis.
@nl
type
label
Metabolic and hepatic effects ...... nonalcoholic steatohepatitis.
@en
Metabolic and hepatic effects ...... nonalcoholic steatohepatitis.
@nl
prefLabel
Metabolic and hepatic effects ...... nonalcoholic steatohepatitis.
@en
Metabolic and hepatic effects ...... nonalcoholic steatohepatitis.
@nl
P2093
P2860
P356
P1476
Metabolic and hepatic effects ...... nonalcoholic steatohepatitis.
@en
P2093
Henrik H Hansen
Jacob Jelsing
Kirstine S Tølbøl
Kristoffer Tg Rigbolt
Michael Feigh
Niels Vrang
Sanne S Veidal
P2860
P304
P356
10.3748/WJG.V24.I2.179
P407
P577
2018-01-01T00:00:00Z